Academic radiology · 2025
Non-cardiovascular Calcification Measures and Warranty Period of a Zero CAC in Young Adults: the Multi-ethnic Study of Atherosclerosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ghotbi Elena, Nasir Khurram, Bancks Michael P, Subhas Nikhil, Akhtarkhavari Sepehr, Shabani Mahsima, Hadidchi Roham, Bluemke David A, Post Wendy S, Budoff Matthew, Graham Barr R, Lima João A C, Demehri Shadpour
Аннотация
RATIONALE AND OBJECTIVES: This study investigates the warranty period for downstream incident coronary artery calcium (CAC) > 0 and cardiovascular disease (CVD) events in young adults (age < 50 years) with baseline CAC=0, stratified by non-cardiovascular calcification. The absence of coronary calcification (CAC=0) is a strong negative risk predictor, especially in young, low-risk individuals, as coronary events without CAC are rare. Beyond known cardiovascular risk factors, propensity for systemic calcium deposition-reflected by non-cardiovascular calcification-may influence incident CAC > 0. Refining risk prediction in young adults, who face cumulative harms from unnecessary imaging and radiation, is important.
MATERIALS AND METHODS: Young adults with baseline CAC score=0 from Exam 1 (2000-2002) of the MESA cohort (n=402) were stratified by costal cartilage calcification (CCC) into below- and above-median groups (n=201 each). A Weibull parametric survival model estimated time-to-conversion to CAC > 0 and CVD events, enabling estimation of the "warranty period" as the mean time to 25% incidence of CAC > 0% and 2% incidence of CVD events.
RESULTS: By Exam 5 (2010-2012), incident CAC > 0 was observed in 27% of the below-median group and 42% of the above-median group. The warranty period for 25% CAC > 0 incidence was shorter in the above-median group (8.0 [95% CI: 7.2, 8.7] vs. 9.6 [8.6, 10.6] years). Conversely, the warranty period for 2% CVD incidence was longer in the above-median group (11.2 [95% CI: 7.4, 18.1] vs. 9.3 [95% CI: 6.5, 14.1] years).
CONCLUSION: In young adults with CAC=0 at baseline, high non-cardiovascular calcification may indicate a shorter CAC > 0 incidence warranty period and possibly less severe atherosclerotic stages, as reflected by a longer warranty period for CVD events.
MATERIALS AND METHODS: Young adults with baseline CAC score=0 from Exam 1 (2000-2002) of the MESA cohort (n=402) were stratified by costal cartilage calcification (CCC) into below- and above-median groups (n=201 each). A Weibull parametric survival model estimated time-to-conversion to CAC > 0 and CVD events, enabling estimation of the "warranty period" as the mean time to 25% incidence of CAC > 0% and 2% incidence of CVD events.
RESULTS: By Exam 5 (2010-2012), incident CAC > 0 was observed in 27% of the below-median group and 42% of the above-median group. The warranty period for 25% CAC > 0 incidence was shorter in the above-median group (8.0 [95% CI: 7.2, 8.7] vs. 9.6 [8.6, 10.6] years). Conversely, the warranty period for 2% CVD incidence was longer in the above-median group (11.2 [95% CI: 7.4, 18.1] vs. 9.3 [95% CI: 6.5, 14.1] years).
CONCLUSION: In young adults with CAC=0 at baseline, high non-cardiovascular calcification may indicate a shorter CAC > 0 incidence warranty period and possibly less severe atherosclerotic stages, as reflected by a longer warranty period for CVD events.